Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Alaunos TherapeuticsTCRT | Open-market sale | 24/12/31 | 25/01/03 | 3,000 sh2 trades | $2.01avg. | $6,021.82 | −10.4% | |
Alaunos TherapeuticsTCRT | Open-market sale10b5-1 plan | 23/09/01 | 23/09/05 | 68,014 sh | $0.14 | $9,521.96 | −7.9% |